CIK 0001585364
- Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +1 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-05 | Andersen Svend EVP & President CHCI | Option exercise | +2,540 | $41.04 | $104K | 19,161 |
| 2021-03-05 | Andersen Svend EVP & President CHCI | Shares withheld for taxes | +55 | $41.04 | $2K | 19,216 |
| 2021-03-05 | Andersen Svend EVP & President CHCI | Grant or award · Restricted Stock Units | +10,234 | 10,234 | ||
| 2021-02-05 | Dillard James E III EVP, Chief Scientific Officer | Option exercise | +4,297 | 8,913 | ||
| 2021-02-05 | Dillard James E III EVP, Chief Scientific Officer | Shares withheld for taxes | −1,396 | $43.09 | $60K | 7,517 |
| 2021-02-05 | Dillard James E III EVP, Chief Scientific Officer | Option exercise · Restricted Stock Units | −4,297 | 4,297 | ||
| 2021-01-06 | Sorota Richard S EVP & President CSCA | Purchase | +7,513 | $43.48 | $327K | 7,513 |
| 2020-11-09 | CLASSON ROLF A Director | Purchase | +2,137 | $46.75 | $100K | 10,870 |
| 2020-11-09 | Samuels Theodore R. II Director | Purchase | +4,500 | $46.91 | $211K | 18,118 |
| 2020-08-14 | Willis Robert EVP & CHRO | Option exercise | +581 | $53.40 | $31K | 2,358 |
| 2020-08-14 | Willis Robert EVP & CHRO | Shares withheld for taxes | −303 | $53.40 | $16K | 2,055 |
| 2020-08-14 | Willis Robert EVP & CHRO | Option exercise · Restricted Stock Units | −581 | 1,160 | ||
| 2020-08-12 | Doyle Katherine C. Director | Grant or award · Restricted Stock Units | +5,637 | 5,637 | ||
| 2020-08-11 | Andersen Svend EVP & President CHCI | Purchase | +2,828 | $53.01 | $150K | 10,028 |
| 2020-06-29 | Janish Ronald Craig EVP, Global Op. & Supply Chain | Option exercise | +827 | $54.56 | $45K | 9,429 |
| 2020-06-29 | Janish Ronald Craig EVP, Global Op. & Supply Chain | Shares withheld for taxes | −361 | $54.56 | $20K | 9,068 |
| 2020-06-29 | Janish Ronald Craig EVP, Global Op. & Supply Chain | Option exercise · Restricted Stock Units | −827 | 0 | ||
| 2020-06-29 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +262 | $54.56 | $14K | 4,796 |
| 2020-06-29 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −137 | $54.56 | $7K | 4,659 |
| 2020-06-29 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −262 | 0 |
Page 44 of 47 · 921 trades